Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD

Universitat de Girona

Status: Completed

Conditions: Attention Deficit-hyperactivity Disorder

Treatments: Other: TDApp1: an eHealth intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04228094

tdapp1

Details and patient eligibility

About

This is a 3-week open label, one group study to determine the agreement between the pharmacological treatment recommended by TDApp1 and the interventions recommended by relevant clinical practice guidelines.

Full description

Clinical practice guidelines (CPGP) allow optimizing medical decisions and health care based on the best evidence available. Nevertheless, CPGs have several limitations. First, many GPC are outdated shortly after their publication. Second, CPG recommendations are often not applicable to many patients treated in clinical practice. Most CPGs do not make recommendations for patients with a mild disorder or for complex patients with comorbiditie. Another limitation is that patients involvement in CPGs development is still poor.

We aim to develop and assess TDApp1: an eHealth tool to formulate participatory, individualized and automated therapeutic recommendations for patients with Attention Deficit Hyperactivity Disorder.

A 3-week, one group, open label study will be conducted. Fifty-five patients aged 6-65 with ADHD will use TDApp1. The therapeutic recommendations made by the TDApp1 and by relevant CPG will be compared. Concordance in the recommendations will be studied. Effectiveness, safety, changes in physical activity and satisfaction will be investigated.

Enrollment: 33 patients

Sex: All

Ages: 6 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female patients ages 6-65
• A diagnosis of DSM-V ADHD based on clinical assessment

Exclusion criteria

• Patients under adequate therapeutic treatment or requiring minor adjustments
• Patients lacking an electronic device (mobile phone, tablet,...) with internet access

Trial design

33 participants in 1 patient group

TDApp1

Description:

This cohort will use TDApp1: an eHealth tool to formulate participatory, individualized and automated therapeutic recommendations for patients with Attention Deficit Hyperactivity Disorder

Treatment:

Other: TDApp1: an eHealth intervention